RecruitingPhase 3NCT06959095
Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation
Sponsor: GlaxoSmithKline
St Louis, MO · +41 more sites
COPD clinical trials in St Louis, MO
6 recruiting copd studies with a site in St Louis, MO.
RecruitingPhase 3NCT06283966
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
Sponsor: AstraZeneca
Kansas City, MO · Liberty, MO · St Louis, MO · +232 more sites
RecruitingPhase 3NCT07190222
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
Sponsor: Sanofi
Columbia, MO · Hannibal, MO · St Louis, MO · +73 more sites
RecruitingPhase 2NCT07082738
A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
Sponsor: AstraZeneca
Chesterfield, MO · Hannibal, MO · St Louis, MO · +83 more sites
RecruitingPhase 3NCT06883305
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
Sponsor: AstraZeneca
St Louis, MO · +71 more sites
RecruitingPhase 2 / Phase 3NCT07363694
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
Sponsor: Pfizer
St Louis, MO · +58 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.